|
|
GovernmentDocs 5/5/2008 | 0 (0) | 38 | 0 | 0 | English
FDA PERFORMANCE PLAN SUMMARYFDA???s FY 2002 Performance Plan is organized into two parts. ??? Part One describes an overview of FDA, its mission and long term goals, strategies for achieving the ... more>>
bnummer 8/8/2008 | 10 (1) | 302 | 5 | 0 | 0
This is a Spanish (Puerto Rican dialect) translation of the US FDA 2005 Model Food Code done by state regulators in PR. ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 55 | 1 | 0 | English
FDA Electronic Submissions Gateway (ESG)User Guide November 20, 2007Table Of Contents1 Introduction ... more>>
FDADocs 5/9/2008 | 0 (0) | 27 | 0 | 0 | English
FDA Assistance to IndustryMarie Falcone FDA ORA CER Small Business Representative... entrepreneurs??? Facilitate access to guidance, policies, regulations, and laws enforced by FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
Center for Food Safety and Applied NutritionJanuary 2003 PROTECTING THE FOOD SUPPLY:FDA Actions on New Bioterrorism Legislation On June 12 President George W. Bush signed into law the Public ... more>>
FDADocs 5/5/2008 | 0 (0) | 37 | 0 | 0 | English
Nomination and Approval of CBER Inspectors and Product Specialists Assigned to Conduct Inspections of Biological Products SOPP 8505 APPENDIX 2MEMORANDUM Department of Health an... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 75 | 1 | 0 | English
What is the relationship between FDA's Quality System Regulation for Devices, Part 820, and ISO 9001:2000? FDA's Quality System Regulation Part 820, is harmonized with ISO 13485:1996, which is based ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 37 | 0 | 0 | English
April 11, 2006Dear Pravastatin ANDA applicant: This letter is prompted by the March 16, 2006, opinion of the District of Columbia Circuit Court of Appeals, Teva Pharmaceuticals USA, Inc. v. FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
April 11, 2006Dear Pravastatin ANDA applicant: This letter is prompted by the March 16, 2006, opinion of the District of Columbia Circuit Court of Appeals, Teva Pharmaceuticals USA, Inc. v. FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 29 | 0 | 0 | English
FDA CONSOLIDATED CITIZEN PETITION RESPONSE REFERENCE:06/1999 04/2003FDA draft guidance, Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 42 | 0 | 0 | English
further delay enforcement of FDA??? well-founded decision to withdraw approval for the use of Baytril s and other fluoroquinolone antibiotics in poultry. It has been more than three years since FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
Errata for the FDA Briefing Document fo Atrasentan for the September 13, 2005 ODAC Meeting NDA 21-491The following changes should be made to the FDA briefing document for Atrasentan 1. Page ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 23 | 0 | 0 | English
ADDENDUM to FDA???s Guidance for Industry: PDMA Pedigree Requirements ??? Questions and Answers... FDA from implementing 21 CFR ?? 203.50(a). 21 CFR ?? 203.50(a)(6), states that information regarding ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
administrative burden to both the FDA and to foreign establishments arising out of a requirement that each ... more>>
FDADocs 5/9/2008 | 0 (0) | 27 | 0 | 0 | English
administrative burden to both the FDA and to foreign establishments arising out of a requirement that each ... more>>
| | | |
| results / page 15/25/50 |
Page: 3 of 32
|
3...
|
|